2017
DOI: 10.1016/j.msec.2016.11.006
|View full text |Cite
|
Sign up to set email alerts
|

Bioflavonoid hesperetin overcome bicalutamide induced toxicity by co-delivery in novel SNEDDS formulations: Optimization, in vivo evaluation and uptake mechanism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(7 citation statements)
references
References 34 publications
0
6
0
1
Order By: Relevance
“…No significant increase in the serum urea and serum creatinine levels in the Hst-treated group was observed compared to the control group, indicating no potential nephrotoxicity. In addition, the normal architecture of spleen, heart, intestine, and liver were not affected after 14 days of toxicological evaluation . As is a very promising and safe functional food with greater benefits in health, the low bioavailability, insufficient research on absorption, distribution, metabolism, and excretion, and lack of clinical data restricted its clinical application.…”
Section: Background Information On Hesperetinmentioning
confidence: 99%
See 1 more Smart Citation
“…No significant increase in the serum urea and serum creatinine levels in the Hst-treated group was observed compared to the control group, indicating no potential nephrotoxicity. In addition, the normal architecture of spleen, heart, intestine, and liver were not affected after 14 days of toxicological evaluation . As is a very promising and safe functional food with greater benefits in health, the low bioavailability, insufficient research on absorption, distribution, metabolism, and excretion, and lack of clinical data restricted its clinical application.…”
Section: Background Information On Hesperetinmentioning
confidence: 99%
“…In addition, the normal architecture of spleen, heart, intestine, and liver were not affected after 14 days of toxicological evaluation. 31 As is a very promising and safe functional food with greater benefits in health, the low bioavailability, insufficient research on absorption, distribution, metabolism, and excretion, and lack of clinical data restricted its clinical application. More in-depth research on these issues is urgently needed.…”
Section: Background Information On Hesperetinmentioning
confidence: 99%
“…Surfactants, co-surfactants, and oil ak [44]; surfactant (Cremophor® EL), co-surfactant (Capmul® MCM-C8) and oil phase (lemon essential oil: Permata; 1: 1) [45] Emulsion droplet size, PDI, % drug loading and zeta potential [45]; globule size (R1) and% encapsulation efficiency (R2 BCT and R2 HSP) hesperetin [46]; Visual characterization, turbidity, average droplet size, polydispersity index [47] Polypeptide-k [45]; Bioflavonoid hesperetin [46]; Gemfibrozil [47,51]…”
Section: Transdermal Patchesmentioning
confidence: 99%
“…Básicamente los SEDDS están constituidos por tres componentes: un principio activo, una fase oleosa y un tensioactivo [56]. Sin embargo, en algunas ocasiones puede presentarse la incorporación de excipientes adicionales para mejorar algunas características o el desempeño del sistema como por ejemplo, cosolventes [57], mucoadhesivos [58], inhibidores de la precipitación [59], etc.…”
Section: Composiciónunclassified